The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes. by Boultwood, J, Dolatshad, H, Varanasi, S, Yip, B, Pellagatti, A

Rectal Cancer Metastasis to the Anal Verge: An Unusual Case Presentation and Review of the Literature by Johnson GGRJ, Yip B, Helewa RM, Shariff F, Hyun E

Get full text

Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies. by Boultwood, J, Yip, B, Vuppusetty, C, Pellagatti, A, Wainscoat, J

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients by Bello, E, Kerry, J, Singh, S, Yip, B, Kušec, R, Killick, S, Raynaud, S, Boultwood, J, Pellagatti, A

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells. by Davies, C, Yip, B, Fernandez-Mercado, M, Woll, P, Agirre, X, Prosper, F, Jacobsen, SE, Wainscoat, J, Pellagatti, A, Boultwood, J

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells by Davies, C, Yip, B, Fernandez-Mercado, M, Woll, P, Agirre, X, Prosper, F, Jacobsen, SE, Wainscoat, J, Pellagatti, A, Boultwood, J

Carotid artery stenosis: accuracy of noninvasive tests--individual patient data meta-analysis. by Chappell, F, Wardlaw, J, Young, G, Gillard, J, Roditi, G, Yip, B, Pell, J, Rothwell, P, Brown, M, Gough, M, Randall, MS

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts. by Yip, B, Pellagatti, A, Vuppusetty, C, Giagounidis, A, Germing, U, Lamikanra, A, Roberts, D, Fernandez-Mercado, M, McDonald, E, Killick, S, Wainscoat, J, Boultwood, J

Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts by Yip, B, Pellagatti, A, Vuppusetty, C, Giagounidis, A, Germing, U, Lamikanra, A, Roberts, D, Fernandez-Mercado, M, McDonald, E, Killick, S, Wainscoat, J, Boultwood, J

Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts. by Yip, B, Vuppusetty, C, Attwood, M, Giagounidis, A, Germing, U, Lamikanra, A, Roberts, D, Maciejewski, J, Vandenberghe, P, Mecucci, C, Wainscoat, J, Pellagatti, A, Boultwood, J

Activation of the mTOR Signaling Pathway by L-Leucine in RPS14-Deficient Erythroid Cells by Yip, B, Vuppusetty, C, Pellagatti, A, Giagounidis, A, Germing, U, Lamikanra, A, Roberts, D, Fernandez-Mercado, M, McDonald, E, Mecucci, C, Killick, S, Wainscoat, J, Boultwood, J

Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts by Yip, B, Vuppusetty, C, Attwood, M, Giagounidis, A, Germing, U, Lamikanra, A, Roberts, D, MacIejewski, J, Vandenberghe, P, Mecucci, C, Wainscoat, J, Pellagatti, A, Boultwood, J

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics by Fernandez-Mercado, M, Yip, B, Pellagatti, A, Davies, C, Larrayoz, M, Kondo, T, Pérez, C, Killick, S, McDonald, E, Odero, MD, Agirre, X, Prósper, F, Calasanz, M, Wainscoat, J, Boultwood, J

PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia by Chase, A, Pellagatti, A, Singh, S, Score, J, Tapper, W, Lin, F, Hoade, Y, Bryant, C, Trim, N, Yip, B, Zoi, K, Rasi, C, Forsberg, L, Dumanski, J, Boultwood, J, Cross, N

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes by Dolatshad, H, Repapi, E, Steeples, V, Roy, S, Scifo, L, Armstrong, R, Shaw, J, Yip, B, Taylor, S, Boultwood, J, Liberante, F, Llorian, M, Killick, S, Kusec, R, Mills, K, Savage, K, Smith, C, Pellagatti, A

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations by Pellagatti, A, Steeples, V, Sharma, E, Repapi, E, Yip, B, Armstrong, R, Dolatshad, H, Lockstone, H, Taylor, S, Giagounidis, A, Vyas, P, Papaemmanuil, E, Woll, P, Killick, S, Malcovati, L, Hellstrom-Lindberg, E, Cazzola, M, Smith, C, Boultwood, J

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes. by Yip, B, Steeples, V, Repapi, E, Armstrong, R, Llorian, M, Roy, S, Shaw, J, Dolatshad, H, Taylor, S, Verma, A, Bartenstein, M, Vyas, P, Cross, N, Malcovati, L, Cazzola, M, Hellström-Lindberg, E, Ogawa, S, Smith, C, Pellagatti, A, Boultwood, J

TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients. by Caceres, G, McGraw, K, Yip, B, Pellagatti, A, Johnson, J, Zhang, L, Liu, K, Zhang, L, Fulp, W, Lee, J, Al Ali, N, Basiorka, A, Smith, L, Daugherty, F, Littleton, N, Wells, R, Sokol, L, Wei, S, Komrokji, R, Boultwood, J, List, A